logo

BNTC

Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)

BNTC fundamentals

Benitec Biopharma (BNTC) released its earnings on May 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.24 (YoY +85.37%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.24
+85.37%
Report date
May 14, 2025
EPS
Q3,2018
Q4,undefined
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-10.54-10.03-6.8-10.54-7.99-3.4-2.72-0.01-2.76-2.64-1.641.04-0.48-0.33-0.24
Forecast
-12.75-14.45-15.81-7.48-4.76-3.145-1.87-3.4-3.23-0.51-0.39-0.78-0.4875-0.55-0.7757-0.3483
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+9.09%
-121.43%
-154.05%
-81.82%
+20.00%
+99.69%
-441.18%
-576.92%
-110.26%
+313.33%
+12.73%
+57.46%
+31.09%
Revenue
Q3,2018
Q4,undefined
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
----------025.00K48.00K0014.00K54.00K15.00K0000000
Forecast
----35.00K5.00K5.00K----009.50K0000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call